Premier Stock Price, News & Analysis

Premier, Inc. (NASDAQ: PINC) has secured a significant five-year group purchasing agreement with Premier Infusion and Healthcare Services, Inc. The partnership will support Premier Infusion and HCS's expansion into the ambulatory infusion clinic market with an estimated annual contract spend exceeding $50 million.

Premier Infusion and HCS, a closed-door infusion pharmacy based in Torrance, California, currently serves seven states and aims to expand its geographic footprint. Through this agreement, they will leverage Premier's extensive purchasing network, supply chain management services, and technology to enhance operational efficiency and cost containment while scaling their growth in outpatient infusion services.

Premier Inc (NASDAQ: PINC), a leading healthcare improvement company, has appointed Bruce Radcliff as President of Supply Chain Services, effective September 1, 2025. Radcliff, who joined Premier in May 2023 as Group Vice President of Strategic Sourcing, brings over 15 years of healthcare provider experience and a decade of supply chain leadership.

Prior to Premier, Radcliff led supply chain operations at Advocate Aurora Health, a Premier member health system with over $15 billion in revenue, where he successfully managed product shortages and oversaw comprehensive supply chain operations. In his new role, he will oversee Premier's core supply chain business, including sourcing, contract management, operations, and business analytics.

Premier Inc (NASDAQ:PINC), a technology-driven healthcare improvement company, has announced its upcoming participation in the Baird Global Healthcare Conference. Management will engage in a fireside chat on September 9, 2025, at 8:30 a.m. ET.

Investors can access both the live audio webcast and replay through Premier's investor relations website under the Events and Presentations section.

Premier Inc (NASDAQ:PINC) reported Q4 FY2025 results with total net revenue of $262.9 million, down 12% year-over-year but exceeding company expectations. Q4 GAAP net income from continuing operations was $18.0 million ($0.22 per share), compared to $60.9 million ($0.57 per share) in the prior year.

For full-year FY2025, the company generated operating cash flow of $417.8 million and free cash flow of $180.5 million, both surpassing expectations. The Supply Chain Services segment showed resilience despite contract renewal headwinds, while Performance Services revenue declined 20% YoY.

Looking ahead, Premier provided FY2026 guidance with total net revenue excluding Contigo Health projected at $940 million to $1 billion, adjusted EBITDA of $230-245 million, and adjusted EPS of $1.33-1.43. The company completed a $200 million accelerated share repurchase program and maintains its quarterly dividend of $0.21 per share.

Premier Inc (NASDAQ:PINC), a healthcare improvement company, has announced a quarterly cash dividend of $0.21 per share for Class A common stock. The dividend will be paid on September 15, 2025, to shareholders of record as of September 1, 2025.

Premier Inc (NASDAQ:PINC) has scheduled its fiscal 2025 fourth-quarter and full-year financial results release for Tuesday, August 19, 2025, at 6:30 a.m. ET. The company will host a conference call to discuss the results at 8:00 a.m. ET the same day.

Investors can access the live webcast and replay through Premier's website in the Investors section under Events & Presentations. The replay will be available for one year after the broadcast. For those without internet access, the call can be joined via telephone using the toll-free domestic number (833) 953-2438 or international number (412) 317-5767.

Premier, Inc. (NASDAQ: PINC) has announced the acquisition of IllumiCare, a healthcare technology company specializing in EMR-agnostic clinical decision support (CDS) platforms. IllumiCare's platform integrates clinical and financial data at the point of care, helping providers optimize clinical decisions while managing costs.

The acquired technology is currently utilized by over 82,000 providers and is compatible with more than 50 EMR systems. IllumiCare's flagship product identifies inpatient medication and diagnostic procedures that may lack clinical benefit based on medical standards, while attributing actual supply costs to ordering providers. The platform demonstrates a potential return on investment of up to 10 to one.

Premier will integrate IllumiCare's capabilities into its Stanson Health brand, with the combined solution launching this summer. The enhanced platform will support various healthcare initiatives, including care gap closure, coding accuracy improvement, outpatient risk capture, clinical trial optimization, and value-based payment model success. Financial terms of the acquisition were not disclosed.

Premier (NASDAQ: PINC) has announced its annual 15 Top Health Systems® study results, highlighting the nation's best-performing healthcare systems. The comprehensive analysis reveals that if all health systems matched the top performers' standards, over 171,000 additional lives could have been saved and 336,000 more patients could have avoided complications in 2025. The study evaluates health systems across four pillars: clinical outcomes, extended outcomes, operational efficiency, and patient experience. Top performers demonstrated significant advantages over peers, including 22% fewer inpatient deaths, 21.6% fewer complications, 17.4% fewer healthcare-associated infections, and 0.5-day shorter hospital stays. The analysis uses public data from MEDPAR and CMS Care Compare, categorizing systems into large, medium, and small groups for fair comparison.

Premier Inc. (NASDAQ: PINC) has joined HealthVerity Marketplace™ as a data source, enabling life sciences organizations to access Premier's comprehensive healthcare datasets. The integration provides access to Premier® Healthcare Database (PHD), one of the largest inpatient and outpatient chargemaster databases with over 25 years of history. The partnership allows access to electronic medical record (EMR) data, including de-identified unstructured clinical notes, supporting research across market access, clinical development, and epidemiological studies.

Through this collaboration, researchers can analyze device and drug utilization patterns, track resource usage and outcomes, and generate insights into care quality, safety, and cost. The integration enhances HealthVerity Marketplace's ecosystem, which currently covers 340 million de-identified individuals, enabling HIPAA-compliant data linkage for comprehensive patient journey insights.